Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesOcean Sciences Ltd

Ocean Sciences Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.011 AUD 0.00 ( 10.00%)
Last update at 2026-11-12T04:10:00Z
VOLUME
2590236
Market Cap
2.82M

Momentum Score

…

Ocean Sciences Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes, and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. Ocean Sciences Ltd was formerly known as BPH Global Ltd and changed its name to Ocean Sciences Ltd in September 2026. The company was incorporated in 1984 and is based in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
3.44M
Revenue Per Share
0.02
Gross Profit TTM
0.06M
Debt / Equity
-
ROE
-
Net Debt
0.38M
ROCE
150.99%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30
Income before tax -2.16M -4.05M -2.95M
Minority interest 0.18M -0.22M -0.75M
Net income -2.65M -4.83M -3.69M
Selling general administrative 1.24M 1.80M 3.32M
Gross profit 0.02M 0.00M 2.29M
Reconciled depreciation - 0.02M 0.24M
Ebit -2.14M -2.51M -2.88M
Ebitda -2.14M -2.49M -2.65M
Operating income -1.75M -2.51M -2.95M
Interest expense 0.02M - 0.06M
Tax provision 0.00M 0.00M 0.00M
Net interest income -0.02M - -0.06M
Total revenue 0.11M 0.00M 14.35M
Cost of revenue 0.09M - 12.07M
Total other income expense net -0.39M -1.54M 0.07M
Net income from continuing ops -2.16M -4.05M -2.95M
Breakdown 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30
Total assets 0.28M 1.47M 7.62M
Intangible assets 0.39M 0.00M 0.00M
Other current assets - 0.00M -
Total liab 1.97M 1.19M 2.44M
Total stockholder equity -1.41M 0.02M 3.20M
Capital stock 78.94M 78.28M 76.88M
Retained earnings -81.82M -80.71M -77.97M
Cash 0.13M 0.51M 0.62M
Total current liabilities 1.70M 1.28M 2.81M
Net debt 0.38M - 0.55M
Short long term debt 0.25M - 1.09M
Total current assets 0.30M 1.26M 5.61M
Long term investments - 0.21M 0.00M
Short term investments 0.00M 0.63M 0.06M
Net receivables - - 4.74M
Long term debt - - 0.09M
Inventory 0.05M - 1.32M
Accounts payable 0.00M 0.00M 0.01M
Noncontrolling interest in consolidated entity -0.01M 0.17M 1.68M
Non current assets total 0.39M 0.84M 1.55M
Capital lease obligations - - 0.12M
Breakdown 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30
Net borrowings 0.38M -0.08M 0.34M
Total cash from financing activities 0.70M 1.38M 0.28M
Net income -2.65M -4.83M -3.69M
Change in cash -0.38M -0.04M -4.65M
Begin period cash flow 0.51M 0.62M 5.26M
End period cash flow 0.13M 0.51M 0.62M
Issuance of capital stock 0.32M 1.49M -
Capital expenditures 0.00M 0.06M 0.91M
Free cash flow -1.26M -1.49M -4.93M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OSS
Ocean Sciences Ltd		 0.00
10.00%		 0.01 - - 0.82 2.63 0.77 -3.90
AFP
Aft Pharmaceuticals Ltd		 0.05
1.41%		 3.60 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd		 0.09
3.42%		 2.72 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd		 0.01
16.67%		 0.07 - 10.00 0.64 0.60 1.25 19.47
MVP
Medical Developments International Ltd		 -
-%		 0.44 40.00 166.67 1.06 0.79 0.57 7.45

Profile*

Ocean Sciences Ltd

Ocean Sciences Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes, and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. Ocean Sciences Ltd was formerly known as BPH Global Ltd and changed its name to Ocean Sciences Ltd in September 2026. The company was incorporated in 1984 and is based in Melbourne, Australia.

365 Little Collins Street, Melbourne, VIC, Australia, 3000

61 2 9088 2049

https://bphglobal.com

Name Title Year Born
Mr. Francesco Cannavo Interim Executive Chairman NA
Mr. Matthew Robert Leonard MD & Executive Director NA
Mr. Chow-Yee Koh Chief Financial Officer 1976
Ms. Ifat Mazouz Chief Scientific Officer NA
Mr. Justyn Peter Stedwell B.Com. Company Secretary 1981
Mr. Deepak Jha Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…